Thrombocytopenia associated with chronic hepatitis

Thrombocytopenia associated with chronic hepatitis is a hematologic complication characterized by an abnormally low peripheral blood platelet count (typically below 150,000/µL) occurring in patients with persistent inflammatory liver disease, most commonly due to chronic hepatitis C or hepatitis B infection Clinically, affected individuals may exhibit mucocutaneous bleeding, petechiae, or ecchymoses, and the deficiency frequently complicates clinical management by increasing hemorrhage risk duri...

Thrombocytopenia associated with chronic hepatitis is a hematologic complication characterized by an abnormally low peripheral blood platelet count (typically below 150,000/µL) occurring in patients with persistent inflammatory liver disease, most commonly due to chronic hepatitis C or hepatitis B infection

Thrombocytopenia associated with chronic hepatitis is a hematologic complication characterized by an abnormally low peripheral blood platelet count (typically below 150,000/µL) occurring in patients with persistent inflammatory liver disease, most commonly due to chronic hepatitis C or hepatitis B infection

Thrombocytopenia associated with chronic hepatitis is a hematologic complication characterized by an abnormally low peripheral blood platelet count (typically below 150,000/µL) occurring in patients with persistent inflammatory liver disease, most commonly due to chronic hepatitis C or hepatitis B infection It arises through a multifactorial pathophysiology that includes reduced hepatic synthesis of thrombopoietin from parenchymal injury, splenic sequestration secondary to portal hypertension an...

It arises through a multifactorial pathophysiology that includes reduced hepatic synthesis of thrombopoietin from parenchymal injury, splenic sequestration secondary to portal hypertension and hypersplenism, direct viral bone marrow suppression of megakaryopoiesis, and immune-mediated platelet destruction via autoantibodies or immune complexes Clinically, affected individuals may exhibit mucocutaneous bleeding, petechiae, or ecchymoses, and the deficiency frequently complicates clinical manageme...

It arises through a multifactorial pathophysiology that includes reduced hepatic synthesis of thrombopoietin from parenchymal injury, splenic sequestration secondary to portal hypertension and hypersplenism, direct viral bone marrow suppression of megakaryopoiesis, and immune-mediated platelet destruction via autoantibodies or immune complexes

Clinically, affected individuals may exhibit mucocutaneous bleeding, petechiae, or ecchymoses, and the deficiency frequently complicates clinical management by increasing hemorrhage risk during invasive diagnostic or therapeutic procedures